The Chronic Pruritus Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Chronic Pruritus Therapeutics Market?
The global market for chronic pruritus therapeutics has seen significant growth recently. The market size is expected to increase from $10.17 billion in 2024 to $10.94 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Chronic Pruritus Therapeutics Industry?
The Chronic Pruritus Therapeutics Global Market Report 2025 predicts that by 2029, the market will reach a size of $14.49 billion, growing at a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Chronic Pruritus Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Chronic Pruritus Therapeutics Market?
The key drivers in the chronic pruritus therapeutics market are:
• Rising awareness about chronic pruritus conditions
• Increase in atopic dermatitis cases
• Growing focus on personalized medicine
• Constant rise in prevalence of dermatological conditions.
Global Market Segmentation: Identifying Major Chronic Pruritus Therapeutics Industry Segments
The chronic pruritus therapeutics market covered in this report is segmented –
1) By Product Type: Corticosteroid, Antihistamine, Local Anesthetic, Counterirritant, Immunosuppressant, Calcineurin Inhibitors, Other Product Types
2) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Other Disease Types
3) By Distribution Channel: Hospital Pharmacies, Drug stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Corticosteroid: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Antihistamine: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetic: Topical Local Anesthetics, Injectable Local Anesthetics
4) By Counterirritant: Menthol-Based Counterirritants, Camphor-Based Counterirritants
5) By Immunosuppressant: Systemic Immunosuppressants, Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus-Based Therapy, Pimecrolimus-Based Therapy
7) By Other Product Types: Biologic Therapies, Emerging Novel Therapies
Pre-order the 2025 Chronic Pruritus Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Chronic Pruritus Therapeutics Market?
The key trends in the chronic pruritus therapeutics market are:
• The introduction of innovative medicines is shaping future trends in the chronic pruritus therapeutics market.
• There is a focus on the development of novel biologics and targeted therapies.
• The integration of advanced drug delivery systems is an emerging trend.
• Digital health technologies, including telemedicine, are influencing the progression of the market.
Who Are the Top Competitors & Leading Players in the Chronic Pruritus Therapeutics Market?
Major players in the chronic pruritus therapeutics market are:
• Pfizer Incorporated
• AbbVie Inc.
• Sanofi S.A.
• Novartis Aktiengesellschaft
• GlaxoSmithKline plc
• Toray Industries Inc.
• CSL Behring LLC
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Ipsen S.A.
• Incyte Corporation
• Cipla Limited
• H. Lundbeck A/S
• Sumitomo Pharma Co. Ltd.
• Mallinckrodt Pharmaceuticals plc
• Kissei Pharmaceutical Co. Ltd.
• Asana BioSciences LLC
• Vanda Pharmaceuticals Inc.
• Dermavant Sciences Inc.
• Galderma Laboratories L.P.
• Cara Therapeutics Inc.
• Avior Bio Inc.
• Trevi Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the chronic pruritus therapeutics market in 2024
